Quantitative Systematic Strategies LLC Cti Biopharma Corp Transaction History

Quantitative Systematic Strategies LLC

  • $0
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 16, 2021
SELL
$2.25 - $3.18 $57,793 - $81,681
-25,686 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$2.16 - $2.62 $697 - $846
-323 Reduced 1.24%
25,686 $64,000
Q1 2021

May 06, 2021
BUY
$2.68 - $3.8 $13,429 - $19,041
5,011 Added 23.86%
26,009 $76,000
Q4 2020

Feb 09, 2021
BUY
$2.48 - $3.8 $52,075 - $79,792
20,998 New
20,998 $68,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Quantitative Systematic Strategies LLC Portfolio

Follow Quantitative Systematic Strategies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email